Nanocarrier-Based Drug-Delivery System in Herpes Simplex Virus Treatment

References

• James C , HarfoucheM , WeltonNJet al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ.98(5), 315–329 (2020).
   PubMed Web of Science ®Google Scholar
• Joob B , WiwanitkitV. Nanotechnology for health: a new useful technology in medicine. Med. J. D.Y. Patil Uni.10(5), 401–405 (2017).
   Google Scholar
• Yang X , ShahSJ , WangZ , AgrahariV , PalD , MitraAK. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Drug Deliv.23(7), 2399–2409 (2016).
   PubMed Web of Science ®Google Scholar
• Xue J , WuT , DaiY , XiaY. Electrospinning and electrospun nanofibers: methods, materials, and applications. Chem. Rev.119(8), 5298–5415 (2019).
   PubMed Web of Science ®Google Scholar
• Tyo KM , LasnikAB , ZhangLet al. Sustained-release Griffithsin nanoparticle-fiber composites against HIV-1 and HSV-2 infections. J. Control Release321, 84–99 (2020).
   PubMed Web of Science ®Google Scholar
• Kumar A , VimalA , KumarA. Why Chitosan? From properties to perspective of mucosal drug delivery. Int. J. Biol. Macromol.91, 615–622 (2016).
   PubMed Web of Science ®Google Scholar
• Donalisio M , ArgenzianoM , RittàMet al. Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections. Int. J. Pharm.587, 119676 (2020).
   PubMedGoogle Scholar
• Donalisio M , LeoneF , CivraAet al. Acyclovir-loaded chitosan nanospheres from nano-emulsion templating for the topical treatment of herpesviruses infections. Pharmaceutics10(2), 46 (2018).
   PubMed Web of Science ®Google Scholar
• Donalisio M , ArgenzianoM , RittaMet al. Acyclovir-loaded sulfobutyl ether-beta-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections. Int. J. Pharm.587, 119676 (2020).
   PubMedGoogle Scholar
• Sangboonruang S , SemakulN , SookkreeSet al. Activity of propolis nanoparticles against HSV-2: promising approach to inhibiting infection and replication. Molecules27(8), 2560 (2022).
   PubMed Web of Science ®Google Scholar
• He X , XingR , LiuSet al. The improved antiviral activities of amino-modified chitosan derivatives on Newcastle virus. Drug Chem. Toxicol.44(4), 335–340 (2021).
   PubMed Web of Science ®Google Scholar
• Safarzadeh M , SadeghiS , AziziM , Rastegari-PouyaniM , PouriranR , HajiMolla Hoseini M. Chitin and chitosan as tools to combat COVID-19: a triple approach. Int. J. Biol. Macromol.183, 235–244 (2021).
   PubMed Web of Science ®Google Scholar
• Loutfy SA , ElberryMH , FarrohKYet al. Antiviral activity of chitosan nanoparticles encapsulating curcumin against hepatitis C virus genotype 4a in human hepatoma cell lines. Int. J. Nanomedicine15, 2699–2715 (2020).
   PubMed Web of Science ®Google Scholar
• Szymanska E , CzarnomysyR , JacynaJet al. Could spray-dried microbeads with chitosan glutamate be considered as promising vaginal microbicide carriers? The effect of process variables on the in vitro functional and physicochemical characteristics. Int. J. Pharm.568, 118558 (2019).
   PubMedGoogle Scholar
• Szymanska E , KrzyzowskaM , CalKet al. Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers – antiherpes activity and penetration behavior across the human vaginal epithelium. Drug Deliv.28(1), 2278–2288 (2021).
   PubMed Web of Science ®Google Scholar
• Melk MM , El-HawarySS , MelekFRet al. Antiviral activity of zinc oxide nanoparticles mediated by Plumbago indica L. Extract against herpes simplex virus type 1 (HSV-1). Int. J. Nanomed.16, 8221–8233 (2021).
   PubMed Web of Science ®Google Scholar
• Abouaitah K , AllayhAK , WojnarowiczJ , ShakerYM , Swiderska-SrodaA , LojkowskiW. Nanoformulation composed of ellagic acid and functionalized zinc oxide nanoparticles inactivates DNA and RNA viruses. Pharmaceutics13(12), 2174 (2021).
   PubMed Web of Science ®Google Scholar
• Monavari SH , MirzaeiParsa MJ , BolouriB , EbrahimiSA , Ataei-PirkoohA. The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture. Med. J. Islam Repub. Iran28, 99 (2014).
   PubMedGoogle Scholar
• Giongo V , FalangaA , DeMelo CPPet al. Antiviral potential of naphthoquinones derivatives encapsulated within liposomes. Molecules26(21), 6440 (2021).
   PubMed Web of Science ®Google Scholar
• Ron-Doitch S , SawodnyB , KuhbacherAet al. Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV. J. Control Release229, 163–171 (2016).
   PubMed Web of Science ®Google Scholar
• Kopecek J , KopeckovaP. HPMA copolymers: origins, early developments, present, and future. Adv. Drug Deliv. Rev.62(2), 122–149 (2010).
   PubMed Web of Science ®Google Scholar
• Frich CK , KrugerF , WaltherRet al. Non-covalent hitchhiking on endogenous carriers as a protraction mechanism for antiviral macromolecular prodrugs. J. Control Release294, 298–310 (2019).
   PubMed Web of Science ®Google Scholar
• Guerrero-Beltran C , Cena-DiezR , Sepulveda-CrespoDet al. Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2/HIV-1 co-infection. Nanoscale9(44), 17263–17273 (2017).
   PubMed Web of Science ®Google Scholar
• Dey P , BergmannT , Cuellar-CamachoJLet al. Multivalent flexible nanogels exhibit broad-spectrum antiviral activity by blocking virus entry. ACS Nano12(7), 6429–6442 (2018).
   PubMed Web of Science ®Google Scholar
• Aderibigbe BA . Metal-based nanoparticles for the treatment of infectious diseases. Molecules22(8), 1370 (2017).
   PubMed Web of Science ®Google Scholar
• Paradowska E , StudzinskaM , JablonskaAet al. Antiviral effect of nonfunctionalized gold nanoparticles against herpes simplex virus type-1 (HSV-1) and possible contribution of near-field interaction mechanism. Molecules26(19), 5960 (2021).
   PubMed Web of Science ®Google Scholar
• Krzyzowska M , ChodkowskiM , JanickaMet al. Lactoferrin-functionalized noble metal nanoparticles as new antivirals for HSV-2 infection. Microorganisms10(1), 110 (2022).
   PubMed Web of Science ®Google Scholar
• Valimaa H , TenovuoJ , WarisM , HukkanenV. Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread. Virol. J.6(1), 53 (2009).
   PubMedGoogle Scholar
• Cagno V , AndreozziP , D’alicarnassoMet al. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat. Mater.17(2), 195–203 (2018).
   PubMed Web of Science ®Google Scholar
• Rogers JV , ParkinsonCV , ChoiYW , SpeshockJL , HussainSM. A preliminary assessment of silver nanoparticle inhibition of Monkeypox virus plaque formation. Nanoscale Res. Lett.3(4), 129–133 (2008).
   Web of Science ®Google Scholar
• Hu RL , LiSR , KongFJ , HouRJ , GuanXL , GuoF. Inhibition effect of silver nanoparticles on herpes simplex virus 2. Genet Mol. Res.13(3), 7022–7028 (2014).
   PubMed Web of Science ®Google Scholar
• Gaikwad S , IngleA , GadeAet al. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int. J. Nanomedicine8, 4303–4314 (2013).
   PubMed Web of Science ®Google Scholar
• Lin LT , ChenTY , ChungCYet al. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J. Virol.85(9), 4386–4398 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang XF , DaiYC , ZhongWet al. Tannic acid inhibited norovirus binding to HBGA receptors, a study of 50 Chinese medicinal herbs. Bioorg. Med. Chem.20(4), 1616–1623 (2012).
   PubMed Web of Science ®Google Scholar
• Orlowski P , KowalczykA , TomaszewskaEet al. Antiviral activity of tannic acid modified silver nanoparticles: potential to activate immune response in herpes genitalis. Viruses10(10), 524 (2018).
   PubMed Web of Science ®Google Scholar
• Orlowski P , TomaszewskaE , GniadekMet al. Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLOS ONE9(8), e104113 (2014).
   PubMed Web of Science ®Google Scholar
• Mishra YK , AdelungR , RohlC , ShuklaD , SporsF , TiwariV. Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1. Antiviral Res.92(2), 305–312 (2011).
   PubMed Web of Science ®Google Scholar